Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer
ClinicalTrials.gov study NCT01897454. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer
ClinicalTrials.gov study NCT02047500. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung C
ClinicalTrials.gov study NCT02409342. IPD Sharing: Not stated. Countries: 19. Publications: 2.
QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
ClinicalTrials.gov study NCT01231347. IPD Sharing: Not stated. Countries: 32. Publications: 1.
High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT01921751. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pemetrexed Plus Gemcitabine in Renal Cell Cancer
ClinicalTrials.gov study NCT00491075. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors
ClinicalTrials.gov study NCT01862328. IPD Sharing: YES. Countries: 1. Publications: 2.
Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00970684. IPD Sharing: Not stated. Countries: 1. Publications: 1.
First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma
ClinicalTrials.gov study NCT01524991. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT01782690. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer
ClinicalTrials.gov study NCT00234494. IPD Sharing: NO. Countries: 1. Publications: 1.
Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT04163900. IPD Sharing: NO. Countries: 15. Publications: 2.
Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy
ClinicalTrials.gov study NCT02690558. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients
ClinicalTrials.gov study NCT01661088. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
ClinicalTrials.gov study NCT01852890. IPD Sharing: YES. Countries: 1. Publications: 5.
Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung Cancers
ClinicalTrials.gov study NCT02525653. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT01611662. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or
ClinicalTrials.gov study NCT01022996. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial of Gemcitabine With or Without MSC1936369B in Pancreatic Cancer
ClinicalTrials.gov study NCT01016483. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC
ClinicalTrials.gov study NCT00859339. IPD Sharing: NO. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.